Cui Q - Search Results

1

A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells.

Peery R, Cui Q, Kyei-Baffour K, Josephraj S, Huang C, Dong Z, Dai M, Zhang JT, Liu JY. Peery R, et al. Among authors: cui q. Bioorg Med Chem. 2022 Jul 1;65:116761. doi: 10.1016/j.bmc.2022.116761. Epub 2022 Apr 28. Bioorg Med Chem. 2022. PMID: 35504208 Free PMC article.

2

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis.

Ma S, Dong Z, Cui Q, Liu JY, Zhang JT. Ma S, et al. Among authors: cui q. Cancer Lett. 2021 Mar 1;500:11-20. doi: 10.1016/j.canlet.2020.12.009. Epub 2020 Dec 8. Cancer Lett. 2021. PMID: 33301799 Review.

3

Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.

Beebe J, Josephraj S, Wang CJ, Danielson J, Cui Q, Huang C, Barlow L, Zhang RH, Zhang T, Nakshatri H, Dong Z, Li X, Liu JY, Zhang JT. Beebe J, et al. Among authors: cui q. J Med Chem. 2022 Oct 27;65(20):13681-13691. doi: 10.1021/acs.jmedchem.2c00642. Epub 2022 Oct 18. J Med Chem. 2022. PMID: 36257066

4

Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.

Cui Q, Huang C, Liu JY, Zhang JT. Cui Q, et al. J Med Chem. 2023 Dec 28;66(24):16515-16545. doi: 10.1021/acs.jmedchem.3c01130. Epub 2023 Dec 13. J Med Chem. 2023. PMID: 38092421 Free PMC article. Review.

5

Targeting cancer cell mitochondria as a therapeutic approach: recent updates.

Cui Q, Wen S, Huang P. Cui Q, et al. Future Med Chem. 2017 Jun;9(9):929-949. doi: 10.4155/fmc-2017-0011. Epub 2017 Jun 21. Future Med Chem. 2017. PMID: 28636410 Review.

6

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr, Chen ZS. Narayanan S, et al. Among authors: cui q. Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11. Drug Resist Updat. 2020. PMID: 31785545 Review.

7

Editorial: Novel Small-Molecule Agents in Overcoming Multidrug Resistance in Cancers.

Cui Q, Wang C, Zeng L, Zhou QX, Fan YF. Cui Q, et al. Front Chem. 2022 May 4;10:921985. doi: 10.3389/fchem.2022.921985. eCollection 2022. Front Chem. 2022. PMID: 35601552 Free PMC article. No abstract available.

8

Synthesis and biological evaluation of novel bi-gold mitocans in lung cancer cells.

Ding W, Cui Q, Lu W, Du Y, Luo Y, Hu Y, Huang P, Wen S. Ding W, et al. Among authors: cui q. Front Chem. 2023 Dec 11;11:1292115. doi: 10.3389/fchem.2023.1292115. eCollection 2023. Front Chem. 2023. PMID: 38148758 Free PMC article.

9

A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.

Wang L, Zhang X, Chan JY, Shan L, Cui G, Cui Q, Wang Y, Li J, Chen H, Zhang Q, Yu P, Han Y, Wang Y, Lee SM. Wang L, et al. Among authors: cui q, cui g. J Cell Biochem. 2016 Jan;117(1):94-105. doi: 10.1002/jcb.25253. J Cell Biochem. 2016. PMID: 26058377

10

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells.

Cui Q, Cai CY, Gao HL, Ren L, Ji N, Gupta P, Yang Y, Shukla S, Ambudkar SV, Yang DH, Chen ZS. Cui Q, et al. Front Oncol. 2019 Apr 25;9:313. doi: 10.3389/fonc.2019.00313. eCollection 2019. Front Oncol. 2019. PMID: 31106148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,066 results

Search Page

Filters